Filings with the SEC since Dec 14, 2022
227 filings, 6 in the last 30 days
Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)
All 60 events
- Nov 10, 20268-K Regulation FD disclosure 8-K item 7.01
- Nov 6, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026
- Oct 21, 20268-K Regulation FD disclosure 8-K item 7.01
- Oct 19, 20268-K Regulation FD disclosure 8-K item 7.01
- Oct 14, 2026Offering At-the-market program: up to $200M of common stock 424B5 · In accordance with the terms of the Sales Agreement, we may offer and sell shares of our Common Stock having an aggregate offering price of up to $200,000,000 from time to time through or to our Sales Agent.
- Oct 14, 20268-K Material agreement signed 8-K item 1.01
- Aug 13, 20268-K Regulation FD disclosure 8-K item 7.01
- Aug 11, 202610-Q Quarterly report (10-Q) period ended Jun 30, 2026
- May 11, 20268-K Regulation FD disclosure 8-K item 7.01
- May 8, 202610-Q Quarterly report (10-Q) period ended Mar 31, 2026
- Apr 8, 20268-K Unregistered share sale 8-K item 3.02
- Apr 1, 20268-K Director or officer change 8-K item 5.02
- Mar 25, 202610-K Annual report (10-K) period ended Dec 31, 2025
- Mar 13, 2026Offering Shelf registration: shares and other securities, amount not fixed S-3/A · We may, from time to time in one or more offerings, offer and sell up to $1,000,000,000 in the aggregate of common stock, preferred stock, debt securities, warrants and rights to purchase common stock or preferred stock, or any combination of the foregoing, either individually or as units comprised
- Mar 13, 2026SEC letter SEC asked 12 questions about Form S-3 letters 2025-08-12 to 2026-03-13 · Risk factors, China, Crypto assets · no closing letter yet
- Feb 12, 20268-K Regulation FD disclosure 8-K item 7.01
- Feb 6, 2026Offering Shelf registration: shares and other securities, amount not fixed S-3/A · We may, from time to time in one or more offerings, offer and sell up to $1,000,000,000 in the aggregate of common stock, preferred stock, debt securities, warrants and rights to purchase common stock or preferred stock, or any combination of the foregoing, either individually or as units comprised
- Jan 23, 20268-K Regulation FD disclosure 8-K item 7.01
- Dec 29, 20258-K Material agreement signed, Unregistered share sale, Regulation FD disclosure 8-K items 1.01, 3.02, 7.01
- Dec 18, 20258-K Shareholder vote results 8-K item 5.07
- Nov 12, 20258-K Regulation FD disclosure 8-K item 7.01
- Nov 10, 202510-Q Quarterly report (10-Q) period ended Sep 30, 2025
- Oct 17, 2025Offering Shelf registration: shares and other securities, amount not fixed S-3/A · We may, from time to time in one or more offerings, offer and sell up to $1,000,000,000 in the aggregate of common stock, preferred stock, debt securities, warrants and rights to purchase common stock or preferred stock, or any combination of the foregoing, either individually or as units comprised
- Sep 2, 20258-K Unregistered share sale, Change in control, Bylaws or fiscal year changed 8-K items 3.02, 5.01, 5.03
- Sep 2, 20258-K Regulation FD disclosure 8-K item 7.01
- Aug 29, 20258-K Material agreement signed 8-K item 1.01
- Aug 22, 2025Offering Shelf registration: shares and other securities, amount not fixed S-3/A · We may, from time to time in one or more offerings, offer and sell up to $1,000,000,000 in the aggregate of common stock, preferred stock, debt securities, warrants and rights to purchase common stock or preferred stock, or any combination of the foregoing, either individually or as units comprised
- Aug 11, 20258-K Regulation FD disclosure 8-K item 7.01
- Aug 8, 202510-Q Quarterly report (10-Q) period ended Jun 30, 2025
- Jul 28, 2025Offering Shelf registration: shares and other securities, amount not fixed S-3 · We may, from time to time in one or more offerings, offer and sell up to $1,000,000,000 in the aggregate of common stock, preferred stock, debt securities, warrants and rights to purchase common stock or preferred stock, or any combination of the foregoing, either individually or as units comprised
- Jul 23, 20258-K Regulation FD disclosure 8-K item 7.01
- Jul 17, 20258-K Regulation FD disclosure 8-K item 7.01
- Jul 16, 20258-K Bylaws or fiscal year changed, Regulation FD disclosure 8-K items 5.03, 7.01
- Jun 30, 20258-K Regulation FD disclosure 8-K item 7.01
- Jun 20, 20258-K Other events 8-K item 8.01
- Jun 16, 20258-K Regulation FD disclosure 8-K item 7.01
- Jun 16, 20258-K Material agreement signed, Unregistered share sale, Shareholder rights changed, Director or officer change, Bylaws or fiscal year changed 8-K items 1.01, 3.02, 3.03, 5.02, 5.03
- May 28, 20258-K Material agreement signed, Unregistered share sale, Shareholder rights changed, Director or officer change, Bylaws or fiscal year changed, Other events 8-K items 1.01, 3.02, 3.03, 5.02, 5.03, 8.01
- May 9, 202510-Q Quarterly report (10-Q) period ended Mar 31, 2025
- Apr 29, 20258-K Regulation FD disclosure 8-K item 7.01
- Apr 24, 20258-K Regulation FD disclosure 8-K item 7.01
- Apr 16, 20258-K Regulation FD disclosure 8-K item 7.01
- Mar 31, 202510-K Annual report (10-K) period ended Dec 31, 2024
- Feb 27, 20258-K Regulation FD disclosure 8-K item 7.01
- Feb 19, 20258-K Regulation FD disclosure 8-K item 7.01
- Feb 14, 20258-K Regulation FD disclosure 8-K item 7.01
- Feb 13, 20258-K Regulation FD disclosure 8-K item 7.01
- Jan 28, 20258-K Director or officer change 8-K item 5.02
- Jan 13, 20258-K Director or officer change 8-K item 5.02
- Jan 6, 2025SEC letter SEC asked 1 question about Form 10-K for the Year Ended December 31, 2023 letters 2024-12-05 to 2025-01-06 · Controls
- Dec 19, 202410-K Annual report (10-K) (amended) period ended Dec 31, 2023
- Dec 12, 20248-K Regulation FD disclosure 8-K item 7.01
- Dec 10, 20248-K Shareholder vote results 8-K item 5.07
- Dec 6, 2024Offering Sale of 1.6M new shares 424B5 · SRM Entertainment, Inc. (the “Company” or “we” or “our” or “us”) is offering (“Offering”) 1,580,000 shares of our common stock, par value $0.0001 (the “Common Stock”) pursuant to this prospectus supplement, and the accompanying base prospectus and a securities purchase agreement. dated December 5, 2
- Dec 6, 20248-K Material agreement signed 8-K item 1.01
- Dec 5, 20248-K Regulation FD disclosure 8-K item 7.01
- Dec 4, 20248-K Regulation FD disclosure 8-K item 7.01
- Nov 25, 20248-K Regulation FD disclosure 8-K item 7.01
- Nov 14, 20248-K Regulation FD disclosure 8-K item 7.01
- Nov 13, 202410-Q Quarterly report (10-Q) period ended Sep 30, 2024
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind
All 227
Annual & quarterly 15Current reports (8-K) 65Insiders 63Proxy & votes 3Big owners (13D/13G) 11Shares & debt offered 10SEC letters 34Other 26
| Filed | Form | What it is | Period | |
|---|---|---|---|---|
| Nov 26, 2025 | DEF 14A | Proxy statement | Nov 26, 2025 | all files |
| Jul 21, 2025 | DEF 14C | Jul 21, 2025 | all files | |
| Nov 20, 2024 | DEF 14A | Proxy statement | Nov 20, 2024 | all files |
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.